Scientifically proven efficacy
The effectiveness and good tolerability of Pantogar® capsules has been proven in comprehensive scientific studies.
A meta-analysis (evaluation of several studies) of Pantogar® capsules, which comprises the results of 11 scientific studies involving a total of over 1,600 patients, proves the effectiveness of treatment with this combination of active ingredients for diffuse hair loss.
Studies involving Pantogar®
At a dermatology conference in 2012, dermatologist Dr. med. Andreas Finner (Berlin) presented results of a study on the use of a combination of the active ingredients cystine, thiamine, calcium panthothenate and medicinal yeast in women with diffuse hair loss. This meta-analysis comprises the results of 11 scientific studies involving a total of over 1,600 patients and proves the effectiveness of treatment with this combination of active ingredients for diffuse hair loss.
The studies incorporated into this meta-analysis include the following
In a clinical and blinded* study of 30 otherwise healthy women, Lengg and colleagues investigated the effect of a product containing a combination of the active ingredients cystine, thiamine, calcium panthothenate and medicinal yeast for the treatment of diffuse hair loss. Taking the active ingredient medication for 6 months led to a normalisation of the number of hairs that were in the growth phase (anagen hair rate) and improved the overall impression of the hair status (1).
Another clinical and blinded* study by Budde and colleagues of 72 patients showed an increase in the number of hairs in the growth phase (anagen hair rate) in the group treated with a combination of cystine, thiamine, calcium panthothenate and medicinal yeast after just 4 months. Furthermore, the hair quality improved under this combination and at the same time the therapy was well tolerated (2).
In a multicentre observational study by Thomas Bergner, 1,194 patients with diffuse hair loss and 642 patients with nail growth disorders were studied. After 3-6 months of use, the therapeutic effect on hair loss and nail growth was assessed as good or very good by doctors and patients in 87-90% of the cases. The therapy reduced the number of hairs falling out daily to a normal level (80-100 hairs) (3).
Explanation of “blinded”: In this study, neither the doctor nor the patient knew which patients were administered the medication containing the active ingredient
1Lengg, N., et al., Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial. Therapy, 2007. 4(1): p. 59-65.
2Budde, J., et al., [Systemic therapy of diffuse effluvium and hair structure damage]. Hautarzt, 1993. 44(6): p. 380-4.
3Bergner, T., Diffuses Effluvium, Haarstrukturschäden und Nagelwachstumsstörungen erfolgreich therapiert. Der deutsche Dermatologe, 1999. 47(11): p. 881-884.
Millions of satisfied women speak for themselves
For us, however, another confirmation of its efficacy is at least as important: Pantogar® has already impressed and convinced millions of women worldwide.
An extensive survey has shown that the treatment results of ® capsules significantly exceeded the expectations of women.*
70% of all affected women indicate that the success of the Pantogar® treatment significantly exceeded their expectations. Some of these women have told us their personal experience so that other patients can also benefit from the right treatment without unnecessary detours.
* Opinion Market Research & Consulting GmbH, Germany, July 2008